SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (32957)11/22/2009 12:17:55 AM
From: Ian@SI2 Recommendations  Respond to of 52153
 
Wouldn't an impaired flow cause or contribute to a buildup of numerous toxins?

And the current therapies don't stop or even reverse damage. At best, they slow disease progression, sometimes for years between relapses.

Regardless, it's far too early to pronounce this hypothesis as the long awaited cure.

But we can always hope it's a major step for at least a subset.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News